Morgan Stanley Zymergen Inc. Transaction History

Morgan Stanley

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.2 - $3.37 $1.42 Million - $3.99 Million	1,184,659 Added 54.85%	3,344,467 $9.3 Million
Q2 2022 Oct 27, 2022	BUY	$1.12 - $3.03 $749,885 - $2.03 Million	669,541 Added 44.93%	2,159,808 $2.66 Million
Q2 2022 Aug 15, 2022	BUY	$1.12 - $3.03 $749,885 - $2.03 Million	669,541 Added 44.93%	2,159,808 $2.66 Million
Q1 2022 Oct 27, 2022	SELL	$2.88 - $7.02 $1.93 Million - $4.7 Million	-669,541 Reduced 31.0%	1,490,267 $4.31 Million
Q1 2022 May 13, 2022	SELL	$2.88 - $7.02 $2.24 Million - $5.46 Million	-778,469 Reduced 34.31%	1,490,267 $4.31 Million
Q4 2021 Feb 14, 2022	BUY	$6.53 - $14.19 $4.98 Million - $10.8 Million	762,101 Added 50.58%	2,268,736 $15.2 Million
Q3 2021 Nov 15, 2021	BUY	$8.25 - $41.0 $12.4 Million - $61.8 Million	1,506,635 New	1,506,635 $19.8 Million

5.49M

Ticker ZY
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 104,355,000
Market Cap $254M
Description
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to co...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.